NBIX | | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Chief Executive Officer | Feb 13, 2024 | Sale | $133.02 | 2,832 | 376,700 | 514,596 | Feb 15, 2024, 05:43 PM |
XNCR | | Xencor Inc | GORMAN KEVIN CHARLES | Director | Feb 13, 2024 | Buy | $19.12 | 53 | 1,013 | 5,060 | Feb 15, 2024, 04:02 PM |
NBIX | | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Chief Executive Officer | Feb 13, 2024 | Option Exercise | $39.28 | 5,090 | 199,951 | 512,052 | Feb 14, 2024, 05:17 PM |
NBIX | | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Chief Executive Officer | Feb 06, 2024 | Sale | $142.18 | 3,040 | 432,218 | 504,919 | Feb 08, 2024, 07:21 PM |
NBIX | | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Chief Executive Officer | Feb 08, 2024 | Sale | $134.15 | 2,274 | 305,052 | 506,962 | Feb 08, 2024, 07:21 PM |
NBIX | | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Chief Executive Officer | Jan 31, 2024 | Sale | $140.69 | 2,707 | 380,845 | 502,188 | Feb 02, 2024, 07:21 PM |
NBIX | | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Chief Executive Officer | Jan 08, 2024 | Sale | $76.01 | 211,670 | 16,089,830 | 605,589 | Jan 10, 2024, 04:31 PM |
NBIX | | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Chief Executive Officer | Jan 09, 2024 | Sale | $76.80 | 124,046 | 9,526,926 | 561,777 | Jan 10, 2024, 04:31 PM |
NBIX | | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Chief Executive Officer | Aug 21, 2023 | Sale | $107.40 | 9,328 | 1,001,816 | 499,754 | Aug 23, 2023, 08:08 PM |
NBIX | | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Chief Executive Officer | Feb 06, 2023 | Sale | $105.68 | 3,040 | 321,259 | 468,008 | Feb 08, 2023, 07:28 PM |
NBIX | | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Chief Executive Officer | Feb 07, 2023 | Sale | $102.42 | 23,730 | 2,430,315 | 489,322 | Feb 08, 2023, 07:28 PM |
NBIX | | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Chief Executive Officer | Feb 08, 2023 | Sale | $104.30 | 2,274 | 237,185 | 491,365 | Feb 08, 2023, 07:28 PM |
NBIX | | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Chief Executive Officer | Jan 31, 2023 | Sale | $110.08 | 2,707 | 297,997 | 465,278 | Feb 02, 2023, 05:19 PM |
NBIX | | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Chief Executive Officer | Feb 07, 2022 | Sale | $80.82 | 8,710 | 703,907 | 460,801 | Feb 09, 2022, 07:00 PM |
NBIX | | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Chief Executive Officer | Feb 08, 2022 | Sale | $79.49 | 2,274 | 180,768 | 462,844 | Feb 09, 2022, 07:00 PM |
NBIX | | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Chief Executive Officer | Feb 05, 2021 | Sale | $114.16 | 2,422 | 276,505 | 443,249 | Feb 09, 2021, 09:17 PM |
NBIX | | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Chief Executive Officer | Feb 08, 2021 | Sale | $116.75 | 10,466 | 1,221,862 | 452,972 | Feb 09, 2021, 09:17 PM |
NBIX | | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Chief Executive Officer | Jan 08, 2021 | Sale | $59.44 | 616,500 | 36,641,742 | 605,872 | Jan 12, 2021, 04:16 PM |
NBIX | | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Chief Executive Officer | Nov 12, 2020 | Sale | $90.78 | 3,390 | 307,748 | 441,071 | Nov 16, 2020, 06:16 PM |
NBIX | | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Chief Executive Officer | Aug 05, 2020 | Sale | $118.91 | 3,390 | 403,101 | 438,021 | Aug 07, 2020, 07:29 PM |
NBIX | | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Chief Executive Officer | Apr 24, 2020 | Sale | $99.45 | 2,906 | 289,016 | 434,971 | Apr 28, 2020, 08:41 PM |
NBIX | | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Chief Executive Officer | Feb 07, 2020 | Sale | $103.36 | 3,248 | 335,697 | 432,357 | Feb 11, 2020, 07:14 PM |
NBIX | | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Chief Executive Officer | Feb 06, 2020 | Sale | $101.56 | 4,343 | 441,066 | 429,436 | Feb 07, 2020, 06:44 PM |
NBIX | | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Chief Executive Officer | Feb 05, 2020 | Sale | $103.09 | 5,449 | 561,726 | 425,529 | Feb 07, 2020, 06:44 PM |
NBIX | | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Chief Executive Officer | Aug 09, 2019 | Option Exercise | $32.99 | 3,031 | 99,993 | 420,628 | Aug 13, 2019, 04:44 PM |
NBIX | | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Chief Executive Officer | Aug 06, 2019 | Sale | $51.91 | 101,822 | 5,285,269 | 468,508 | Aug 08, 2019, 07:39 PM |
NBIX | | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Chief Executive Officer | Aug 07, 2019 | Sale | $51.89 | 5,518 | 286,333 | 420,356 | Aug 08, 2019, 07:39 PM |
NBIX | | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Chief Executive Officer | Aug 08, 2019 | Sale | $52.15 | 52,660 | 2,746,172 | 443,927 | Aug 08, 2019, 07:39 PM |
NBIX | | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Chief Executive Officer | Feb 06, 2019 | Sale | $84.22 | 4,096 | 344,986 | 417,597 | Feb 08, 2019, 05:09 PM |
NBIX | | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Chief Executive Officer | Feb 04, 2019 | Sale | $88.10 | 3,125 | 275,321 | 408,082 | Feb 06, 2019, 06:03 PM |
NBIX | | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Chief Executive Officer | Feb 05, 2019 | Sale | $88.19 | 4,489 | 395,895 | 413,943 | Feb 06, 2019, 06:03 PM |
NBIX | | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Chief Executive Officer | Jun 28, 2018 | Option Exercise | $9.21 | 57,924 | 533,416 | 404,957 | Jun 29, 2018, 07:32 PM |
NBIX | | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Chief Executive Officer | May 01, 2018 | Sale | $43.26 | 253,664 | 10,972,287 | 473,865 | May 03, 2018, 07:39 PM |
NBIX | | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Chief Executive Officer | Feb 06, 2018 | Option Exercise | $43.71 | 204,091 | 8,920,046 | 442,874 | Feb 07, 2018, 06:06 PM |
NBIX | | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Chief Executive Officer | Feb 05, 2018 | Sale | $83.26 | 5,983 | 498,164 | 342,874 | Feb 07, 2018, 06:06 PM |
NBIX | | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Chief Executive Officer | Jan 16, 2018 | Sale | $78.89 | 3,750 | 295,820 | 336,357 | Jan 18, 2018, 04:09 PM |
NBIX | | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Chief Executive Officer | May 02, 2017 | Sale | $27.91 | 43,478 | 1,213,471 | 354,346 | May 03, 2017, 06:42 PM |
NBIX | | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Chief Executive Officer | Apr 12, 2017 | Sale | $50.42 | 19,596 | 988,085 | 332,913 | Apr 13, 2017, 04:53 PM |
NBIX | | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Chief Executive Officer | Feb 08, 2017 | Option Exercise | $2.59 | 64,161 | 166,177 | 314,703 | Feb 08, 2017, 07:37 PM |
NBIX | | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Chief Executive Officer | Feb 06, 2017 | Sale | $43.18 | 3,010 | 129,972 | 250,542 | Feb 08, 2017, 07:37 PM |
NBIX | | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Chief Executive Officer | Feb 03, 2017 | Sale | $42.55 | 3,125 | 132,969 | 247,802 | Feb 06, 2017, 07:18 PM |
NBIX | | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Chief Executive Officer | Jan 17, 2017 | Sale | $40.65 | 3,750 | 152,438 | 244,677 | Jan 18, 2017, 06:43 PM |
NBIX | | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Chief Executive Officer | Jan 10, 2017 | Sale | $43.28 | 3,750 | 162,300 | 240,927 | Jan 12, 2017, 07:01 PM |
NBIX | | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | President and CEO | Dec 23, 2016 | Option Exercise | $2.59 | 9,100 | 23,569 | 237,177 | Dec 23, 2016, 03:44 PM |
NBIX | | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | President and CEO | Feb 03, 2016 | Sale | $38.04 | 3,125 | 118,875 | 228,077 | Feb 04, 2016, 07:24 PM |
NBIX | | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | President and CEO | Jan 19, 2016 | Sale | $46.70 | 3,750 | 175,125 | 224,952 | Jan 21, 2016, 04:13 PM |
NBIX | | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | President and CEO | Jan 11, 2016 | Sale | $44.17 | 3,750 | 165,637 | 221,202 | Jan 13, 2016, 06:19 PM |
NBIX | | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | President and CEO | Oct 16, 2015 | Sale | $47.77 | 33,500 | 1,600,295 | 217,452 | Oct 19, 2015, 07:58 PM |
NBIX | | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | President and CEO | Mar 24, 2015 | Option Exercise | $22.06 | 80,000 | 1,764,800 | 228,452 | Mar 24, 2015, 06:21 PM |
NBIX | | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | President and CEO | Jan 16, 2015 | Sale | $30.79 | 3,750 | 115,463 | 188,452 | Jan 21, 2015, 02:45 PM |
NBIX | | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | President and CEO | Jan 12, 2015 | Sale | $28.43 | 3,750 | 106,613 | 184,702 | Jan 13, 2015, 05:41 PM |
NBIX | | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | President and CEO | Jan 08, 2015 | Option Exercise | $14.99 | 50,000 | 749,500 | 205,952 | Jan 09, 2015, 04:45 PM |
NBIX | | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | PRESIDENT AND CEO | Dec 18, 2014 | Sale | $12.59 | 125,000 | 1,573,350 | 210,952 | Dec 19, 2014, 07:03 PM |
NBIX | | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | PRESIDENT AND CEO | Dec 19, 2014 | Sale | $24.01 | 15,000 | 360,150 | 180,952 | Dec 19, 2014, 07:03 PM |
NBIX | | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | President and CEO | Jan 10, 2014 | Sale | $18.57 | 3,750 | 69,637 | 180,952 | Jan 13, 2014, 06:26 PM |
NBIX | | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | President and CEO | Jan 07, 2014 | Sale | $16.76 | 108,000 | 1,810,080 | 177,202 | Jan 08, 2014, 05:07 PM |
NBIX | | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | President and CEO | Feb 28, 2011 | Sale | $6.83 | 15,400 | 105,134 | 177,202 | Mar 02, 2011, 05:06 PM |